Search

Author/Creator Toussi, Sima S.

1. Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir. Issue 1 (4th May 2022)

Authors:
Singh, Ravi Shankar P.; Toussi, Sima S.; Hackman, Frances; Chan, Phylinda L.; Rao, Rohit; Allen, Richard; Van Eyck, Lien; Pawlak, Sylvester; Kadar, Eugene P.; Clark, Frances; Shi, Haihong; Anderson, Annaliesa S.; Binks, Michael; Menon, Sandeep; Nucci, Gianluca; Bergman, Arthur
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 1(2022)
Page Start:
101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development. Issue 6 (29th June 2022)

Authors:
Singh, Ravi Shankar P.; Walker, Gregory S.; Kadar, Eugene P.; Cox, Loretta M.; Eng, Heather; Sharma, Raman; Bergman, Arthur J.; Van Eyck, Lien; Hackman, Frances; Toussi, Sima S.; Kalgutkar, Amit S.; Obach, R. Scott
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 6(2022)
Page Start:
1201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Inhibitors. Issue 1 (July 2016)

Authors:
Ardura, Monica I.; Toussi, Sima S.; Siegel, Jane D.; Lu, Ying; Bousvaros, Athos; Crandall, Wallace
Journal:
Journal of pediatric gastroenterology and nutrition
Issue:
Volume 63:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Inhibitors. Issue 1 (July 2016)

Authors:
Ardura, Monica I.; Toussi, Sima S.; Siegel, Jane D.; Lu, Ying; Bousvaros, Athos; Crandall, Wallace
Journal:
Journal of pediatric gastroenterology and nutrition
Issue:
Volume 63:Issue 1(2016)
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment. Issue 4 (5th July 2022)

Authors:
Toussi, Sima S.; Neutel, Joel Michael; Navarro, Jesus; Preston, Richard Alfred; Shi, Haihong; Kavetska, Olga; LaBadie, Robert R.; Binks, Michael; Chan, Phylinda L.S.; Demers, Neil; Corrigan, Brian; Damle, Bharat
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 4(2022)
Page Start:
892
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Procalcitonin Differs in Children With Infection and Children With Disease Flares in Juvenile Idiopathic Arthritis. Issue 3 (April 2021)

Authors:
Trachtman, Rebecca; Murray, Elizabeth; Wang, Cindy M.; Szymonifka, Jackie; Toussi, Sima S.; Walters, Heather; Nellis, Marianne E.; Onel, Karen B.; Mandl, Lisa A.
Journal:
Journal of clinical rheumatology
Issue:
Volume 27:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants. Issue 12 (26th October 2022)

Authors:
Zhu, Tong; Pawlak, Sylvester; Toussi, Sima S.; Hackman, Frances; Thompson, Kimberly; Song, Wei; Salageanu, Joanne; Winter, Erica; Shi, Haihong; Winton, Jennifer; Binks, Michael
Journal:
Clinical pharmacology in drug development
Issue:
Volume 11:Issue 12(2022)
Page Start:
1382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗